Peer-influenced content. Sources you trust. No registration required. This is HCN.


The New England Journal of Medicine

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia

Cardiology June 7th 2024

Annals of Internal Medicine

Benefits and Risks Associated with Statin Therapy for Primary Prevention in Old and Very Old Adults: Real-World Evidence From a Target Trial Emulation Study

Cardiology June 5th 2024

The New England Journal of Medicine

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Cardiology May 22nd 2024

Annals of Internal Medicine

Associations of Testosterone and Related Hormones with All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men

Cardiology May 20th 2024

Cleveland Clinic Journal of Medicine

A 50-year-old Man Presents with Shortness of Breath

Cardiology May 16th 2024

Psych Congress Network

Stimulant Use May Increase Heart Damage Risk in Young Adults with ADHD

Pediatrics May 14th 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form